Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
Novo Nordisk is lowering the price it charges customers who pay out-of-pocket for the weight loss drugs. Mr. Funk was the ...
Andy Richter is celebrating his “physical transformation” on Dancing With the Stars after decades of having his weight be ...
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...
Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.
In a landmark deal announced this month, President Donald Trump negotiated dramatically lower costs for weight-loss drugs ...
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? Investors will be watching what Trump makes happen.
Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback